Oruka Insider Sells $463K in Stock as Shares Rise 650%
Oruka Therapeutics insider Joana Goncalves sold 7,000 shares of Common Stock for $463,000 on April 15, 2026, reducing her direct ownership from 40,377 to 33,377 shares. The sale followed the exercise of 3,500 options and occurred amid a 650% surge in the company's stock price. The transaction is considered a liquidity event for equity-compensated executives.
Tickers: $ORKA
Topics: employee stock options executive transactions SEC filing stock sale